MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Multiple Sclerosis and Related Disorders
Topic
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

487 results · 1 filter active ·
Results by year
20102025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
487 works in the cohort · of 4,299,418page 9 of 10

Labels cover 4 of 487 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 487 of 487 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affno abstractunlabeled
Do we need more clinical trials in secondary progressive MS?
Jeannette Lechner‐Scott, E. Ann Yeh, Michael Levy, Chris Hawkes, Gavin Giovannoni
2022· editorial· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity
1
citations
affno abstractunlabeled
CNS resilience in the progression of MS
Gavin Giovannoni, Christopher H. Hawkes, Jeannette Lechner‐Scott, Michael Levy, E. Ann Yeh
2023· editorial· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · metaepi_narrowconsensus · none
1
citations
affno abstractunlabeled
The biological rabbit hole: Only for the blind
Christopher H. Hawkes, Gavin Giovannoni, Michael Levy, E. Ann Yeh
2022· letter· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · sts+research_integrityconsensus · none
1
citations
affno abstractunlabeled
Beyond the B-cell as a treatment target in multiple sclerosis
Gavin Giovannoni, Christopher H. Hawkes, Jeannette Lechner‐Scott, Michael Levy, E. Ann Yeh
2023· editorial· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · metaepi_narrow+research_integrity
1
citations
affno abstractunlabeled
Efficacy of Satralizumab As Monotherapy in Pre-Specified Subgroups of Sakurastar, a Double-Blind Placebo-Controlled Phase 3 Clinical Study in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Jeffrey L. Bennett, Benjamin Greenberg, Anthony Traboulsee, L Szczechowski, Edward Fox, Svitlana Shkrobot +4 more
2020· article· en· Multiple Sclerosis and Related Disorders· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
1
citations
affno abstractunlabeled
Onset of multiple sclerosis is preventable – time to act now!
Christopher H. Hawkes, Gavin Giovannoni, Michael Levy, E. Ann Yeh
2022· editorial· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · research_integrity
1
citations
affno abstractunlabeled
Is there truly no progression in NMOSD and MOGAD?
Jeannette Lechner‐Scott, Gavin Giovannoni, Hawkes Ch, Michael Levy, Yeh Ea
2025· editorial· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · none
0
citations
affno abstractunlabeled
Brain Age
Rod A. Lea, Stasson Lea, Gavin Giovannoni, Chris Hawkes, Michael L. Levy, E. Ann Yeh +1 more
2025· editorial· en· Multiple Sclerosis and Related Disorders
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
0
citations
affno abstractunlabeled
Depression and anxiety in MS: symptoms or comorbidity?
Jeannette Lechner‐Scott, Gavin Giovannoni, Christopher H. Hawkes, Michael Levy, EA Yeh
2024· editorial· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · metaepi_narrow+research_integrityconsensus · research_integrity
0
citations
affno abstractunlabeled
A glass half empty
Sharon Roman
2025· article· en· Multiple Sclerosis and Related Disorders· Health Professions
distilled prediction:candidate · stsconsensus · none
0
citations
affno abstractunlabeled
Open access publishing and the future of scientific communication
Christopher H. Hawkes, Gavin Giovannoni, Jeannette Lechner‐Scott, Michael Levy, E. Ann Yeh
2024· editorial· en· Multiple Sclerosis and Related Disorders· Health Professions
distilled prediction:candidate · sts+scholarly_communication+research_integrityconsensus · none
0
citations
affno abstractunlabeled
When does multiple sclerosis start?
Gavin Giovannoni, Christopher H. Hawkes, Jeannette Lechner‐Scott, Michaël Lévy, Eric Yeh
2025· editorial· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · metaresearch+metaepi_narrow+research_integrityconsensus · metaepi_narrow+research_integrity
0
citations
affno abstractunlabeled
Book review
Jock Murray
2012· article· en· Multiple Sclerosis and Related Disorders· Medicine
distilled prediction:candidate · insufficient_payloadconsensus · none
0
citations

How this was built: Screen · Findings · About